We are a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 650 employees in the United States, China and Europe, our differentiated technology, global development and manufacturing strategy and expertise provide us with the ability to generate, test and […]

  We are a leading platform of local on-demand retail and delivery in China. We operate JD-Daojia (“JDDJ”), one of China’s largest local on-demand retail platforms by GMV in 2019, and Dada Now, a leading local on-demand delivery platform in China by number of orders in 2019, according to the iResearch Report.

  We are a target discovery and gene editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology. Our proprietary target discovery engine is called “Diamond.” Diamond is a computational platform and a neural network that can identify new cancer immunological targets for T cells and B cells. […]

  We are a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of TGF-ß. We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set […]

  Although we may pursue targets in any industry, we intend to initially focus our search on identifying a prospective target business in financial technology or business process outsourcing, which acts as an essential utility to industries that are core to the economy. We also intend to focus on prospective target businesses that have unseen […]

  We are the world’s first and leading mobile data traffic sharing marketplace, according to Frost & Sullivan. We are the pioneer of introducing the sharing economy business model into the telecommunications industry, creating a marketplace for mobile data traffic. Leveraging our innovative cloud SIM technology and architecture, we redefine the mobile data connectivity experience, allowing […]

We intend to focus on the industries that align with the background of the sponsor, with a particular emphasis placed on the healthcare sector. These industries include healthcare, industrials, consumer, media, technology and technology services. We will seek to acquire established businesses that we believe are fundamentally sound but potentially in need of financial, operational, […]

  Although we may pursue an initial business combination with a target business in any industry or geographic location, we currently intend to focus on opportunities in the smart technology innovations market. Specifically, we intend to target companies that are at the forefront of high technology and are enabling the future evolution of 5G communication, […]

  The company intends to focus on leading, growth-oriented companies across a variety of industries. We do not intend to target industries that are competitive with Starwood Capital Group Holdings, L.P., or Starwood Capital, which includes real estate, lodging, oil and gas and energy infrastructure. Investment opportunities will be sourced from the Founders proprietary network […]

  Our company is principally engaged in real estate services business. During earlier stages of our business, including the last three fiscal years, we engaged in the sale of NetEase Inc. prepaid digital cards, as well as software development business and real estate consulting services. To correspond to the PRC government’s recent initiative to encourage […]